RhumbLine Advisers’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.71M | Buy |
38,953
+353
| +0.9% | +$42.7K | ﹤0.01% | 1442 |
|
|
2025
Q1 | $4.3M | Buy |
38,600
+3,846
| +11% | +$429K | ﹤0.01% | 1436 |
|
|
2024
Q4 | $3.38M | Sell |
34,754
-5,636
| -14% | -$548K | ﹤0.01% | 1618 |
|
|
2024
Q3 | $4.65M | Buy |
40,390
+2,580
| +7% | +$297K | ﹤0.01% | 1469 |
|
|
2024
Q2 | $4.03M | Buy |
37,810
+499
| +1% | +$53.1K | ﹤0.01% | 1511 |
|
|
2024
Q1 | $3.61M | Buy |
37,311
+2,730
| +8% | +$264K | ﹤0.01% | 1595 |
|
|
2023
Q4 | $3.49M | Buy |
34,581
+398
| +1% | +$40.2K | ﹤0.01% | 1621 |
|
|
2023
Q3 | $3.48M | Buy |
34,183
+4,897
| +17% | +$499K | ﹤0.01% | 1555 |
|
|
2023
Q2 | $2.96M | Buy |
+29,286
| New | +$2.96M | ﹤0.01% | 1693 |
|
|
2021
Q1 | – | Sell |
-3,600
| Closed | -$340K | – | 3018 |
|
|
2020
Q4 | $340K | Buy |
+3,600
| New | +$340K | ﹤0.01% | 2616 |
|
|
2016
Q3 | – | Sell |
-33,338
| Closed | -$2.47M | – | 2917 |
|
|
2016
Q2 | $2.47M | Hold |
33,338
| – | – | 0.01% | 1204 |
|
|
2016
Q1 | $2.16M | Buy |
33,338
+893
| +3% | +$58K | 0.01% | 1327 |
|
|
2015
Q4 | $2.5M | Buy |
32,445
+1,785
| +6% | +$138K | 0.01% | 1207 |
|
|
2015
Q3 | $2.53M | Hold |
30,660
| – | – | 0.01% | 1187 |
|
|
2015
Q2 | $2.7M | Sell |
30,660
-12,264
| -29% | -$1.08M | 0.01% | 1216 |
|
|
2015
Q1 | $3.79M | Sell |
42,924
-1,950
| -4% | -$172K | 0.01% | 994 |
|
|
2014
Q4 | $3.73M | Buy |
44,874
+2,695
| +6% | +$224K | 0.01% | 956 |
|
|
2014
Q3 | $3.56M | Hold |
42,179
| – | – | 0.01% | 945 |
|
|
2014
Q2 | $3.42M | Sell |
42,179
-335
| -0.8% | -$27.2K | 0.01% | 1020 |
|
|
2014
Q1 | $3.24M | Buy |
42,514
+893
| +2% | +$68K | 0.01% | 1053 |
|
|
2013
Q4 | $3M | Buy |
41,621
+20,562
| +98% | +$1.48M | 0.01% | 1115 |
|
|
2013
Q3 | $1.45M | Buy |
21,059
+7,366
| +54% | +$506K | ﹤0.01% | 1534 |
|
|
2013
Q2 | $868K | Buy |
+13,693
| New | +$868K | ﹤0.01% | 1863 |
|